Drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 32143932.
- Also identified by DOI 10.1016/j.jpeds.2020.01.070.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Infants born very preterm have a variable baseline risk of bronchopulmonary dysplasia (BPD). Using the example of evidence-based drug therapies to prevent BPD, we designed a visual aid that displays the "number needed to treat" with CIs for caffeine, vitamin A, and hydrocortisone over a range of baseline risks.
Medical subject headings
- Bronchopulmonary Dysplasia
- Caffeine
- Evidence-Based Medicine
- Glucocorticoids
- Hydrocortisone
- Infant, Premature
- Vitamin A